ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Inhalation Sevoflurane Anaesthetic Agent Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-34P14045
Home | Market Reports | Health| Pharmacy
Global Inhalation Sevoflurane Anaesthetic Agent Market Research Report 2023
BUY CHAPTERS

Global Inhalation Sevoflurane Anaesthetic Agent Market Research Report 2025

Code: QYRE-Auto-34P14045
Report
July 2025
Pages:79
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
AbbVie
Baxter
Hengrui
Maruishi
Piramal
Viatris
PT Novell Pharmaceutical
Lunan Pharma

Inhalation Sevoflurane Anaesthetic Agent Market Size

The global market for Inhalation Sevoflurane Anaesthetic Agent was valued at US$ 1195 million in the year 2024 and is projected to reach a revised size of US$ 1527 million by 2031, growing at a CAGR of 3.6% during the forecast period.

Inhalation Sevoflurane Anaesthetic Agent Market

Inhalation Sevoflurane Anaesthetic Agent Market

Sevoflurane is a volatile anesthetic commonly used for induction and maintenance of general anesthesia during surgical procedures. It is favored for its rapid onset and offset of action, making it ideal for both adults and pediatric patients. Sevoflurane is typically inhaled and works by depressing the central nervous system, leading to a reversible loss of consciousness and sensation. Its minimal airway irritation and low blood solubility contribute to smoother anesthesia induction and quicker recovery times compared to other anesthetics. Sevoflurane is widely used due to its safety profile and ease of administration.
The key driver for the Sevoflurane market is the increasing number of surgeries worldwide, driven by the aging population and the rising prevalence of chronic conditions requiring surgical intervention. Sevoflurane is highly preferred due to its rapid onset and recovery, making it ideal for both pediatric and adult patients, particularly in outpatient surgeries. Technological advancements in anesthesia delivery systems and the growing demand for minimally invasive procedures have also contributed to the rising adoption of Sevoflurane in clinical settings. Furthermore, the safety and effectiveness of Sevoflurane in maintaining stable cardiovascular function during anesthesia have enhanced its demand.
One of the main challenges in the Sevoflurane market is its high cost compared to other anesthetic agents, which can limit its accessibility in low- and middle-income regions. Additionally, environmental concerns regarding the use of volatile anesthetics like Sevoflurane, which contribute to greenhouse gas emissions, have led to increased scrutiny and calls for more sustainable alternatives. Regulatory restrictions and the availability of generic alternatives may further impact the market growth, as healthcare providers seek more cost-effective or environmentally friendly options.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Inhalation Sevoflurane Anaesthetic Agent, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Inhalation Sevoflurane Anaesthetic Agent.
The Inhalation Sevoflurane Anaesthetic Agent market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Inhalation Sevoflurane Anaesthetic Agent market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Inhalation Sevoflurane Anaesthetic Agent manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Inhalation Sevoflurane Anaesthetic Agent Market Report

Report Metric Details
Report Name Inhalation Sevoflurane Anaesthetic Agent Market
Accounted market size in year US$ 1195 million
Forecasted market size in 2031 US$ 1527 million
CAGR 3.6%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • 250ml/Bottle
  • 120ml/Bottle
  • Other
Segment by Application
  • Hospital
  • Clinics
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Hengrui, Baxter, Maruishi, AbbVie, Piramal, Viatris, PT Novell Pharmaceutical, Lunan Pharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Inhalation Sevoflurane Anaesthetic Agent manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Inhalation Sevoflurane Anaesthetic Agent in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Inhalation Sevoflurane Anaesthetic Agent Market growing?

Ans: The Inhalation Sevoflurane Anaesthetic Agent Market witnessing a CAGR of 3.6% during the forecast period 2025-2031.

What is the Inhalation Sevoflurane Anaesthetic Agent Market size in 2031?

Ans: The Inhalation Sevoflurane Anaesthetic Agent Market size in 2031 will be US$ 1527 million.

Who are the main players in the Inhalation Sevoflurane Anaesthetic Agent Market report?

Ans: The main players in the Inhalation Sevoflurane Anaesthetic Agent Market are Hengrui, Baxter, Maruishi, AbbVie, Piramal, Viatris, PT Novell Pharmaceutical, Lunan Pharma

What are the Application segmentation covered in the Inhalation Sevoflurane Anaesthetic Agent Market report?

Ans: The Applications covered in the Inhalation Sevoflurane Anaesthetic Agent Market report are Hospital, Clinics, Other

What are the Type segmentation covered in the Inhalation Sevoflurane Anaesthetic Agent Market report?

Ans: The Types covered in the Inhalation Sevoflurane Anaesthetic Agent Market report are 250ml/Bottle, 120ml/Bottle, Other

Recommended Reports

Inhalation & Volatile Agents

Anesthesia Equipment Devices

Anesthetics and Sedation

1 Inhalation Sevoflurane Anaesthetic Agent Market Overview
1.1 Product Definition
1.2 Inhalation Sevoflurane Anaesthetic Agent by Type
1.2.1 Global Inhalation Sevoflurane Anaesthetic Agent Market Value Comparison by Type (2024 VS 2031)
1.2.2 250ml/Bottle
1.2.3 120ml/Bottle
1.2.4 Other
1.3 Inhalation Sevoflurane Anaesthetic Agent by Application
1.3.1 Global Inhalation Sevoflurane Anaesthetic Agent Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Other
1.4 Global Inhalation Sevoflurane Anaesthetic Agent Market Size Estimates and Forecasts
1.4.1 Global Inhalation Sevoflurane Anaesthetic Agent Revenue 2020-2031
1.4.2 Global Inhalation Sevoflurane Anaesthetic Agent Sales 2020-2031
1.4.3 Global Inhalation Sevoflurane Anaesthetic Agent Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Inhalation Sevoflurane Anaesthetic Agent Market Competition by Manufacturers
2.1 Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Manufacturers (2020-2025)
2.2 Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Inhalation Sevoflurane Anaesthetic Agent Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Inhalation Sevoflurane Anaesthetic Agent, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Inhalation Sevoflurane Anaesthetic Agent, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Inhalation Sevoflurane Anaesthetic Agent, Product Type & Application
2.7 Global Key Manufacturers of Inhalation Sevoflurane Anaesthetic Agent, Date of Enter into This Industry
2.8 Global Inhalation Sevoflurane Anaesthetic Agent Market Competitive Situation and Trends
2.8.1 Global Inhalation Sevoflurane Anaesthetic Agent Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Inhalation Sevoflurane Anaesthetic Agent Players Market Share by Revenue
2.8.3 Global Inhalation Sevoflurane Anaesthetic Agent Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Inhalation Sevoflurane Anaesthetic Agent Market Scenario by Region
3.1 Global Inhalation Sevoflurane Anaesthetic Agent Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Inhalation Sevoflurane Anaesthetic Agent Sales by Region: 2020-2031
3.2.1 Global Inhalation Sevoflurane Anaesthetic Agent Sales by Region: 2020-2025
3.2.2 Global Inhalation Sevoflurane Anaesthetic Agent Sales by Region: 2026-2031
3.3 Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Region: 2020-2031
3.3.1 Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Region: 2020-2025
3.3.2 Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Region: 2026-2031
3.4 North America Inhalation Sevoflurane Anaesthetic Agent Market Facts & Figures by Country
3.4.1 North America Inhalation Sevoflurane Anaesthetic Agent Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2020-2031)
3.4.3 North America Inhalation Sevoflurane Anaesthetic Agent Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Inhalation Sevoflurane Anaesthetic Agent Market Facts & Figures by Country
3.5.1 Europe Inhalation Sevoflurane Anaesthetic Agent Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2020-2031)
3.5.3 Europe Inhalation Sevoflurane Anaesthetic Agent Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Inhalation Sevoflurane Anaesthetic Agent Market Facts & Figures by Region
3.6.1 Asia Pacific Inhalation Sevoflurane Anaesthetic Agent Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Inhalation Sevoflurane Anaesthetic Agent Sales by Region (2020-2031)
3.6.3 Asia Pacific Inhalation Sevoflurane Anaesthetic Agent Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Inhalation Sevoflurane Anaesthetic Agent Market Facts & Figures by Country
3.7.1 Latin America Inhalation Sevoflurane Anaesthetic Agent Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2020-2031)
3.7.3 Latin America Inhalation Sevoflurane Anaesthetic Agent Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Inhalation Sevoflurane Anaesthetic Agent Market Facts & Figures by Country
3.8.1 Middle East and Africa Inhalation Sevoflurane Anaesthetic Agent Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2020-2031)
3.8.3 Middle East and Africa Inhalation Sevoflurane Anaesthetic Agent Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Inhalation Sevoflurane Anaesthetic Agent Sales by Type (2020-2031)
4.1.1 Global Inhalation Sevoflurane Anaesthetic Agent Sales by Type (2020-2025)
4.1.2 Global Inhalation Sevoflurane Anaesthetic Agent Sales by Type (2026-2031)
4.1.3 Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Type (2020-2031)
4.2 Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Type (2020-2031)
4.2.1 Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Type (2020-2025)
4.2.2 Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Type (2026-2031)
4.2.3 Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Type (2020-2031)
4.3 Global Inhalation Sevoflurane Anaesthetic Agent Price by Type (2020-2031)
5 Segment by Application
5.1 Global Inhalation Sevoflurane Anaesthetic Agent Sales by Application (2020-2031)
5.1.1 Global Inhalation Sevoflurane Anaesthetic Agent Sales by Application (2020-2025)
5.1.2 Global Inhalation Sevoflurane Anaesthetic Agent Sales by Application (2026-2031)
5.1.3 Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Application (2020-2031)
5.2 Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Application (2020-2031)
5.2.1 Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Application (2020-2025)
5.2.2 Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Application (2026-2031)
5.2.3 Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Application (2020-2031)
5.3 Global Inhalation Sevoflurane Anaesthetic Agent Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Hengrui
6.1.1 Hengrui Company Information
6.1.2 Hengrui Description and Business Overview
6.1.3 Hengrui Inhalation Sevoflurane Anaesthetic Agent Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Hengrui Inhalation Sevoflurane Anaesthetic Agent Product Portfolio
6.1.5 Hengrui Recent Developments/Updates
6.2 Baxter
6.2.1 Baxter Company Information
6.2.2 Baxter Description and Business Overview
6.2.3 Baxter Inhalation Sevoflurane Anaesthetic Agent Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Baxter Inhalation Sevoflurane Anaesthetic Agent Product Portfolio
6.2.5 Baxter Recent Developments/Updates
6.3 Maruishi
6.3.1 Maruishi Company Information
6.3.2 Maruishi Description and Business Overview
6.3.3 Maruishi Inhalation Sevoflurane Anaesthetic Agent Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Maruishi Inhalation Sevoflurane Anaesthetic Agent Product Portfolio
6.3.5 Maruishi Recent Developments/Updates
6.4 AbbVie
6.4.1 AbbVie Company Information
6.4.2 AbbVie Description and Business Overview
6.4.3 AbbVie Inhalation Sevoflurane Anaesthetic Agent Sales, Revenue and Gross Margin (2020-2025)
6.4.4 AbbVie Inhalation Sevoflurane Anaesthetic Agent Product Portfolio
6.4.5 AbbVie Recent Developments/Updates
6.5 Piramal
6.5.1 Piramal Company Information
6.5.2 Piramal Description and Business Overview
6.5.3 Piramal Inhalation Sevoflurane Anaesthetic Agent Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Piramal Inhalation Sevoflurane Anaesthetic Agent Product Portfolio
6.5.5 Piramal Recent Developments/Updates
6.6 Viatris
6.6.1 Viatris Company Information
6.6.2 Viatris Description and Business Overview
6.6.3 Viatris Inhalation Sevoflurane Anaesthetic Agent Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Viatris Inhalation Sevoflurane Anaesthetic Agent Product Portfolio
6.6.5 Viatris Recent Developments/Updates
6.7 PT Novell Pharmaceutical
6.7.1 PT Novell Pharmaceutical Company Information
6.7.2 PT Novell Pharmaceutical Description and Business Overview
6.7.3 PT Novell Pharmaceutical Inhalation Sevoflurane Anaesthetic Agent Sales, Revenue and Gross Margin (2020-2025)
6.7.4 PT Novell Pharmaceutical Inhalation Sevoflurane Anaesthetic Agent Product Portfolio
6.7.5 PT Novell Pharmaceutical Recent Developments/Updates
6.8 Lunan Pharma
6.8.1 Lunan Pharma Company Information
6.8.2 Lunan Pharma Description and Business Overview
6.8.3 Lunan Pharma Inhalation Sevoflurane Anaesthetic Agent Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Lunan Pharma Inhalation Sevoflurane Anaesthetic Agent Product Portfolio
6.8.5 Lunan Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Inhalation Sevoflurane Anaesthetic Agent Industry Chain Analysis
7.2 Inhalation Sevoflurane Anaesthetic Agent Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Inhalation Sevoflurane Anaesthetic Agent Production Mode & Process Analysis
7.4 Inhalation Sevoflurane Anaesthetic Agent Sales and Marketing
7.4.1 Inhalation Sevoflurane Anaesthetic Agent Sales Channels
7.4.2 Inhalation Sevoflurane Anaesthetic Agent Distributors
7.5 Inhalation Sevoflurane Anaesthetic Agent Customer Analysis
8 Inhalation Sevoflurane Anaesthetic Agent Market Dynamics
8.1 Inhalation Sevoflurane Anaesthetic Agent Industry Trends
8.2 Inhalation Sevoflurane Anaesthetic Agent Market Drivers
8.3 Inhalation Sevoflurane Anaesthetic Agent Market Challenges
8.4 Inhalation Sevoflurane Anaesthetic Agent Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
AbbVie
Baxter
Hengrui
Maruishi
Piramal
Viatris
PT Novell Pharmaceutical
Lunan Pharma
List of Tables
 Table 1. Global Inhalation Sevoflurane Anaesthetic Agent Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Inhalation Sevoflurane Anaesthetic Agent Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Inhalation Sevoflurane Anaesthetic Agent Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Inhalation Sevoflurane Anaesthetic Agent Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Inhalation Sevoflurane Anaesthetic Agent Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Inhalation Sevoflurane Anaesthetic Agent Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Inhalation Sevoflurane Anaesthetic Agent, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Inhalation Sevoflurane Anaesthetic Agent, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Inhalation Sevoflurane Anaesthetic Agent, Product Type & Application
 Table 12. Global Key Manufacturers of Inhalation Sevoflurane Anaesthetic Agent, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Inhalation Sevoflurane Anaesthetic Agent by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inhalation Sevoflurane Anaesthetic Agent as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Inhalation Sevoflurane Anaesthetic Agent Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Inhalation Sevoflurane Anaesthetic Agent Sales by Region (2020-2025) & (K Units)
 Table 18. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Region (2020-2025)
 Table 19. Global Inhalation Sevoflurane Anaesthetic Agent Sales by Region (2026-2031) & (K Units)
 Table 20. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Region (2026-2031)
 Table 21. Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Region (2020-2025)
 Table 23. Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Region (2026-2031)
 Table 25. North America Inhalation Sevoflurane Anaesthetic Agent Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2020-2025) & (K Units)
 Table 27. North America Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2026-2031) & (K Units)
 Table 28. North America Inhalation Sevoflurane Anaesthetic Agent Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Inhalation Sevoflurane Anaesthetic Agent Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Inhalation Sevoflurane Anaesthetic Agent Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Inhalation Sevoflurane Anaesthetic Agent Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Inhalation Sevoflurane Anaesthetic Agent Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Inhalation Sevoflurane Anaesthetic Agent Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Inhalation Sevoflurane Anaesthetic Agent Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Inhalation Sevoflurane Anaesthetic Agent Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Inhalation Sevoflurane Anaesthetic Agent Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Inhalation Sevoflurane Anaesthetic Agent Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Inhalation Sevoflurane Anaesthetic Agent Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Inhalation Sevoflurane Anaesthetic Agent Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Inhalation Sevoflurane Anaesthetic Agent Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Inhalation Sevoflurane Anaesthetic Agent Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Inhalation Sevoflurane Anaesthetic Agent Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Inhalation Sevoflurane Anaesthetic Agent Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Inhalation Sevoflurane Anaesthetic Agent Sales (K Units) by Type (2020-2025)
 Table 51. Global Inhalation Sevoflurane Anaesthetic Agent Sales (K Units) by Type (2026-2031)
 Table 52. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Type (2020-2025)
 Table 53. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Type (2026-2031)
 Table 54. Global Inhalation Sevoflurane Anaesthetic Agent Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Inhalation Sevoflurane Anaesthetic Agent Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Type (2020-2025)
 Table 57. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Type (2026-2031)
 Table 58. Global Inhalation Sevoflurane Anaesthetic Agent Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Inhalation Sevoflurane Anaesthetic Agent Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Inhalation Sevoflurane Anaesthetic Agent Sales (K Units) by Application (2020-2025)
 Table 61. Global Inhalation Sevoflurane Anaesthetic Agent Sales (K Units) by Application (2026-2031)
 Table 62. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Application (2020-2025)
 Table 63. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Application (2026-2031)
 Table 64. Global Inhalation Sevoflurane Anaesthetic Agent Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Inhalation Sevoflurane Anaesthetic Agent Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Application (2020-2025)
 Table 67. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Application (2026-2031)
 Table 68. Global Inhalation Sevoflurane Anaesthetic Agent Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Inhalation Sevoflurane Anaesthetic Agent Price (US$/Unit) by Application (2026-2031)
 Table 70. Hengrui Company Information
 Table 71. Hengrui Description and Business Overview
 Table 72. Hengrui Inhalation Sevoflurane Anaesthetic Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Hengrui Inhalation Sevoflurane Anaesthetic Agent Product
 Table 74. Hengrui Recent Developments/Updates
 Table 75. Baxter Company Information
 Table 76. Baxter Description and Business Overview
 Table 77. Baxter Inhalation Sevoflurane Anaesthetic Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Baxter Inhalation Sevoflurane Anaesthetic Agent Product
 Table 79. Baxter Recent Developments/Updates
 Table 80. Maruishi Company Information
 Table 81. Maruishi Description and Business Overview
 Table 82. Maruishi Inhalation Sevoflurane Anaesthetic Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Maruishi Inhalation Sevoflurane Anaesthetic Agent Product
 Table 84. Maruishi Recent Developments/Updates
 Table 85. AbbVie Company Information
 Table 86. AbbVie Description and Business Overview
 Table 87. AbbVie Inhalation Sevoflurane Anaesthetic Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. AbbVie Inhalation Sevoflurane Anaesthetic Agent Product
 Table 89. AbbVie Recent Developments/Updates
 Table 90. Piramal Company Information
 Table 91. Piramal Description and Business Overview
 Table 92. Piramal Inhalation Sevoflurane Anaesthetic Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Piramal Inhalation Sevoflurane Anaesthetic Agent Product
 Table 94. Piramal Recent Developments/Updates
 Table 95. Viatris Company Information
 Table 96. Viatris Description and Business Overview
 Table 97. Viatris Inhalation Sevoflurane Anaesthetic Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Viatris Inhalation Sevoflurane Anaesthetic Agent Product
 Table 99. Viatris Recent Developments/Updates
 Table 100. PT Novell Pharmaceutical Company Information
 Table 101. PT Novell Pharmaceutical Description and Business Overview
 Table 102. PT Novell Pharmaceutical Inhalation Sevoflurane Anaesthetic Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. PT Novell Pharmaceutical Inhalation Sevoflurane Anaesthetic Agent Product
 Table 104. PT Novell Pharmaceutical Recent Developments/Updates
 Table 105. Lunan Pharma Company Information
 Table 106. Lunan Pharma Description and Business Overview
 Table 107. Lunan Pharma Inhalation Sevoflurane Anaesthetic Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Lunan Pharma Inhalation Sevoflurane Anaesthetic Agent Product
 Table 109. Lunan Pharma Recent Developments/Updates
 Table 110. Key Raw Materials Lists
 Table 111. Raw Materials Key Suppliers Lists
 Table 112. Inhalation Sevoflurane Anaesthetic Agent Distributors List
 Table 113. Inhalation Sevoflurane Anaesthetic Agent Customers List
 Table 114. Inhalation Sevoflurane Anaesthetic Agent Market Trends
 Table 115. Inhalation Sevoflurane Anaesthetic Agent Market Drivers
 Table 116. Inhalation Sevoflurane Anaesthetic Agent Market Challenges
 Table 117. Inhalation Sevoflurane Anaesthetic Agent Market Restraints
 Table 118. Research Programs/Design for This Report
 Table 119. Key Data Information from Secondary Sources
 Table 120. Key Data Information from Primary Sources
 Table 121. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Inhalation Sevoflurane Anaesthetic Agent
 Figure 2. Global Inhalation Sevoflurane Anaesthetic Agent Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Inhalation Sevoflurane Anaesthetic Agent Market Share by Type: 2024 & 2031
 Figure 4. 250ml/Bottle Product Picture
 Figure 5. 120ml/Bottle Product Picture
 Figure 6. Other Product Picture
 Figure 7. Global Inhalation Sevoflurane Anaesthetic Agent Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Inhalation Sevoflurane Anaesthetic Agent Market Share by Application: 2024 & 2031
 Figure 9. Hospital
 Figure 10. Clinics
 Figure 11. Other
 Figure 12. Global Inhalation Sevoflurane Anaesthetic Agent Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Inhalation Sevoflurane Anaesthetic Agent Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Inhalation Sevoflurane Anaesthetic Agent Sales (2020-2031) & (K Units)
 Figure 15. Global Inhalation Sevoflurane Anaesthetic Agent Average Price (US$/Unit) & (2020-2031)
 Figure 16. Inhalation Sevoflurane Anaesthetic Agent Report Years Considered
 Figure 17. Inhalation Sevoflurane Anaesthetic Agent Sales Share by Manufacturers in 2024
 Figure 18. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Inhalation Sevoflurane Anaesthetic Agent Players: Market Share by Revenue in Inhalation Sevoflurane Anaesthetic Agent in 2024
 Figure 20. Inhalation Sevoflurane Anaesthetic Agent Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Inhalation Sevoflurane Anaesthetic Agent Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Country (2020-2031)
 Figure 23. North America Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Country (2020-2031)
 Figure 24. United States Inhalation Sevoflurane Anaesthetic Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Inhalation Sevoflurane Anaesthetic Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Country (2020-2031)
 Figure 27. Europe Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Inhalation Sevoflurane Anaesthetic Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Inhalation Sevoflurane Anaesthetic Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Inhalation Sevoflurane Anaesthetic Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Inhalation Sevoflurane Anaesthetic Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Inhalation Sevoflurane Anaesthetic Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Region (2020-2031)
 Figure 35. China Inhalation Sevoflurane Anaesthetic Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Inhalation Sevoflurane Anaesthetic Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Inhalation Sevoflurane Anaesthetic Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Inhalation Sevoflurane Anaesthetic Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Inhalation Sevoflurane Anaesthetic Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. China Taiwan Inhalation Sevoflurane Anaesthetic Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Indonesia Inhalation Sevoflurane Anaesthetic Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Thailand Inhalation Sevoflurane Anaesthetic Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Malaysia Inhalation Sevoflurane Anaesthetic Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Inhalation Sevoflurane Anaesthetic Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Inhalation Sevoflurane Anaesthetic Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Inhalation Sevoflurane Anaesthetic Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey Inhalation Sevoflurane Anaesthetic Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Inhalation Sevoflurane Anaesthetic Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. UAE Inhalation Sevoflurane Anaesthetic Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of Inhalation Sevoflurane Anaesthetic Agent by Type (2020-2031)
 Figure 55. Global Revenue Market Share of Inhalation Sevoflurane Anaesthetic Agent by Type (2020-2031)
 Figure 56. Global Inhalation Sevoflurane Anaesthetic Agent Price (US$/Unit) by Type (2020-2031)
 Figure 57. Global Sales Market Share of Inhalation Sevoflurane Anaesthetic Agent by Application (2020-2031)
 Figure 58. Global Revenue Market Share of Inhalation Sevoflurane Anaesthetic Agent by Application (2020-2031)
 Figure 59. Global Inhalation Sevoflurane Anaesthetic Agent Price (US$/Unit) by Application (2020-2031)
 Figure 60. Inhalation Sevoflurane Anaesthetic Agent Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

Global Sevoflurane For Inhalation Market Research Report 2024
Global Inhalation Sevoflurane Anesthesia Drugs Market Research Report 2024
Global Medical Sevoflurane Market Research Report 2024
Global Sevoflurane Market Research Report 2024
Global Sevoflurane Sevoflurane Source Market Research Report 2024
Global Sevoflurane Anesthesia Drugs Market Research Report 2024
Global Inhalational Isoflurane Market Research Report 2024
Global Isoflurane Anesthesia Drugs Market Research Report 2024
Global Sevoflurane Source Market Insights Forecast to 2030
Global Inhalation Anesthesia Drugs Market Research Report 2024
Global Inhalation General Anesthesia Drugs Market Research Report 2024
Global Desflurane Market Research Report 2024
Global Inhalational Anaesthesia Drugs Market Research Report 2024
Global Anesthesia Gas Market Research Report 2024
Global Inhalation Sedatives Market Research Report 2024
Sevoflurane Anesthesia Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Inhalational Anesthesia Drugs Market Research Report 2024
Global Inhalational Anesthetic Market Research Report 2024
Global Sevoflurane Anesthesia Vaporizers Market Research Report 2024
Global Sevoflurane and Isoflurane Anesthesia Vaporizers Market Research Report 2024

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions